M&A Deal Summary

ATS Medical Acquires 3F Therapeutics

On January 24, 2006, ATS Medical acquired medical products company 3F Therapeutics

Acquisition Highlights
  • This is ATS Medical’s 1st transaction in the Medical Products sector.
  • This is ATS Medical’s 1st transaction in the United States.
  • This is ATS Medical’s 1st transaction in California.

M&A Deal Summary

Date 2006-01-24
Target 3F Therapeutics
Sector Medical Products
Buyer(s) ATS Medical
Deal Type Add-on Acquisition

Target

3F Therapeutics

Lake Forest, California, United States
3F Therapeutics, Inc. is an early stage medical device company emerging field of minimally invasive beating heart tissue valve replacement.

Search 201,429 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

ATS Medical

Minneapolis, Minnesota, United States

Category Company
Founded 1992
Sector Medical Products
Employees245
DESCRIPTION

ATS Medical, Inc., engages in the development, manufacture and marketing of medical devices for the treatment of structural heart diseases. It offers prosthetic heart valves, such as ATS Open Pivot Heart Valve, as well as ATS 3F Aortic Bioprosthesis, a biological replacement aortic heart valve and heart valve repair products. The company also markets and sells surgical cryoablation products for the treatment of cardiac arrhythmias, and it is developing minimally invasive and off-pump aortic valve concepts.


DEAL STATS #
Overall 1 of 2
Sector (Medical Products) 1 of 1
Type (Add-on Acquisition) 1 of 1
State (California) 1 of 1
Country (United States) 1 of 1
Year (2006) 1 of 1
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2007-06-28 CryoCath - Surgical Ablation Business

Canada

CryoCath - Surgical Ablation Business is a provider allograft tissue services, and the development of PARSUS blood filtration technology.

Buy -